HDV vs XBI
iShares Core High Dividend ETF vs SPDR S&P Biotech ETF
- • HDV has the lower expense ratio at 0.08% vs 0.35% for XBI.
- • HDV pays a higher dividend yield (3.09%).
Side-by-side metrics
| Metric | HDV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.35% |
Dividend yield Trailing 12-month yield. | 3.09% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $16.28B | $10.92B |
YTD return | 28.80% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.20 | 1.01 |
P/E ratio | 19.53 | — |
Last price | $30.57 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
HDV top holdings
| XOM | ExxonMobil Holdings Corp | 9.62% |
| CVX | Chevron Corp | 7.27% |
| ABBV | AbbVie Inc | 6.80% |
| PG | Procter & Gamble Co | 5.40% |
| VZ | Verizon Communications Inc | 5.08% |
| PM | Philip Morris International Inc | 5.06% |
| HD | The Home Depot Inc | 4.61% |
| KO | Coca-Cola Co | 4.28% |
| PEP | PepsiCo Inc | 3.90% |
| MO | Altria Group Inc | 3.88% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About HDV
HDV (iShares Core High Dividend ETF) is US high-dividend stocks with quality screen. Managed by iShares, the fund carries $16.3B in assets under management, an expense ratio of 0.08%, a dividend yield of 3.09%. Its largest holding is ExxonMobil Holdings Corp (XOM), which represents 9.6% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.